Clinical Trials Directory

Trials / Unknown

UnknownNCT02614963

Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome

Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome: A Randomized, Double-blinded,Placebo- Controlled Multicenter Study

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Clostridium Butyricum might be an effective drug in treating irritable bowel syndrome

Conditions

Interventions

TypeNameDescription
DRUGClostridium ButyricumIrritable bowel syndrome patients treated with Clostridium Butyricum
DRUGplaceboIrritable bowel syndrome patients treated with placebo

Timeline

Start date
2015-12-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2015-11-25
Last updated
2016-05-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02614963. Inclusion in this directory is not an endorsement.